NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00143-9786-01 — enalaprilat 1.25 mg/mL intravenous solutionAI (468 hospitals, 59,353–60,541 samples)
• NDC 00409-9046-01 — Bupivacaine with epinephrine 0.5% injectionAI (240 hospitals, 59,289–60,414 samples)
• NDC 51754-5012-01 — Sodium bicarbonate 4.2% solution, 10 mL vialAI (461 hospitals, 58,475–60,401 samples)
• NDC 60687-0395-79 — Albuterol 2.5 mg nebulizer solutionAI (513 hospitals, 57,753–60,228 samples)
• NDC 00487-9601-01 — Budesonide 0.25 mg/2 mL inhalation suspensionAI (680 hospitals, 59,015–60,158 samples)
• NDC 51754-5011-01 — Sodium bicarbonate 8.4% IV solutionAI (260 hospitals, 58,207–60,142 samples)
• NDC 00019-1333-21 — Iodinated contrast dye (ioversol 350) for intravenous useAI (41 hospitals, 59,409–60,138 samples)
• NDC 00019-1333-11 — Iodinated contrast dye, injectable solutionAI (71 hospitals, 59,409–60,138 samples)
• NDC 00019-1323-11 — Ioversol 320 contrast injection for imagingAI (134 hospitals, 59,408–60,128 samples)
• NDC 00054-0045-44 — Ipratropium bromide 0.03% nasal sprayAI (551 hospitals, 58,759–60,127 samples)
• NDC 00641-6013-10 — Diltiazem 25 mg/5 mL intravenous injectionAI (649 hospitals, 57,491–60,110 samples)
• NDC 00143-9532-25 — Dexmedetomidine 100 mcg/mL IV solutionAI (288 hospitals, 58,011–60,108 samples)
• NDC 00338-0017-03 — Dextrose 5% intravenous solutionAI (742 hospitals, 57,035–60,068 samples)
• NDC 00641-6238-01 — Ephedrine sulfate injection for intravenous useAI (242 hospitals, 58,898–60,014 samples)
• NDC 71288-0202-02 — Sodium nitroprusside intravenous solutionAI (286 hospitals, 58,798–59,977 samples)
• NDC 63323-0426-05 — Rocuronium injection, 5 mL vialAI (493 hospitals, 57,193–59,965 samples)
• NDC 55150-0221-10 — Etomidate intravenous solution 2 mg/mLAI (626 hospitals, 58,247–59,948 samples)
• NDC 63323-0782-20 — Vecuronium bromide 20 mg injection for IV useAI (220 hospitals, 58,075–59,947 samples)
• NDC 00781-3269-95 — EPHEDRINE 50MG/ML VIAL 1MLAI (350 hospitals, 58,834–59,932 samples)
• NDC 00517-7504-01 — Acetylcysteine 10% solutionAI (295 hospitals, 58,926–59,916 samples)
• NDC 63323-0086-50 — Potassium phosphate intravenous solutionAI (232 hospitals, 58,942–59,860 samples)
• NDC 00409-6625-14 — Sodium bicarbonate 8.4% IV solutionAI (513 hospitals, 56,944–59,797 samples)
• NDC 42367-0540-32 — Dantrolene 250 mg vialAI (759 hospitals, 58,110–59,784 samples)
• NDC 63323-0424-05 — Flumazenil injection, 5 mL vialAI (883 hospitals, 57,383–59,768 samples)
• NDC 00143-9786-10 — Enalaprilat injection, 1.25 mg/mL intravenous solutionAI (637 hospitals, 57,888–59,751 samples)
• NDC 51754-5001-04 — Sodium bicarbonate 8.4% solution, 50 mL vialAI (519 hospitals, 58,362–59,703 samples)
• NDC 55150-0209-02 — Dexmedetomidine sedation medication, 200 mcg per 2 mL injectionAI (654 hospitals, 57,780–59,679 samples)
• NDC 00378-9671-30 — Ipratropium and albuterol nebulizer solutionAI (291 hospitals, 57,197–59,618 samples)
• NDC 55150-0236-01 — Vecuronium bromide 20 mg IV injectionAI (199 hospitals, 57,991–59,611 samples)
• NDC 00409-3382-11 — Sufentanil citrate IV injectionAI (247 hospitals, 56,683–59,581 samples)
• NDC 2751001 — Insulin lispro 100 unit/mL vialAI (130 hospitals, 59,453–59,561 samples)
• NDC 70860-0605-03 — Dexmedetomidine sedation medication, IV solutionAI (279 hospitals, 56,910–59,520 samples)
• NDC 25021-0673-77 — Glydo 2% topical sprayAI (723 hospitals, 57,874–59,503 samples)
• NDC 65219-0445-10 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (351 hospitals, 58,047–59,487 samples)
• NDC 42023-0114-10 — Ketamine 50 mg/mL injectionAI (451 hospitals, 57,914–59,462 samples)
• NDC 00409-4713-75 — Lidocaine 1% injection solutionAI (198 hospitals, 54,738–59,427 samples)
• NDC 63323-0165-16 — Dexamethasone sodium phosphate 4 mg/mL injectionAI (348 hospitals, 53,751–59,412 samples)
• NDC 67457-0852-04 — Norepinephrine intravenous solution, 1 mg/mLAI (492 hospitals, 58,207–59,395 samples)
• NDC 43066-0007-10 — Rocuronium injection, 10 mg per mLAI (446 hospitals, 56,753–59,363 samples)
• NDC 63323-0462-37 — Sensorcaine with epinephrine local anesthetic injectionAI (807 hospitals, 57,795–59,325 samples)
• NDC 00409-1746-71 — Bupivacaine with epinephrine injection (preservative-free)AI (362 hospitals, 58,027–59,314 samples)
• NDC 00006-5423-02 — Sugammadex sodium injection, 200 mg/2 mLAI (658 hospitals, 54,756–59,274 samples)
• NDC 00409-6695-01 — etomidate 2 mg/mL intravenous solutionAI (459 hospitals, 57,789–59,238 samples)
• NDC 63323-0492-09 — Lidocaine 1% numbing injection, preservative-freeAI (427 hospitals, 49,069–59,221 samples)
• NDC 00409-9043-01 — Bupivacaine with epinephrine 0.25% injectionAI (254 hospitals, 58,254–59,190 samples)
• NDC 63323-0468-17 — Bupivacaine with epinephrine numbing injectionAI (580 hospitals, 57,271–59,188 samples)
• NDC 72266-0146-10 — etomidate 2 mg/mL intravenous solutionAI (369 hospitals, 57,817–59,185 samples)
• NDC 00409-4900-24 — Sodium bicarbonate 8.4% IV solutionAI (215 hospitals, 58,419–59,157 samples)
• NDC 67457-0251-00 — Dexmedetomidine 100 mcg/mL IV solutionAI (185 hospitals, 57,914–59,138 samples)
• NDC 55150-0222-20 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (458 hospitals, 56,779–59,056 samples)